Join us on March 17th at 8pmET for a free, patient‑friendly webinar with expert John Strickler, MD from Duke University. In this informative educational event, Dr Strickler will explain how ctDNA testing works, how it can help detect cancer recurrence earlier, and how it may guide treatment and follow‑up decisions.
Register & Submit Your Question Here
You’ll learn what ctDNA and molecular residual disease (MRD) mean, why not all ctDNA tests are the same, and why repeat (serial) testing matters. Patients and caregivers are invited to submit questions in advance for Dr. Strickler, who will answer as many as possible during the live Q&A. Register and Submit Your Question Now
About Dr Strickler
John Strickler, MD, is a gastrointestinal medical oncologist at Duke University whose clinical and research work focuses on precision medicine for colorectal and other GI cancers, including the use of circulating tumor DNA (ctDNA) and molecular residual disease (MRD) testing to guide care. He serves as a Professor of Medicine and a leader in Duke’s Precision Cancer Medicine and Investigational Therapeutics Program, where he helps design and run clinical trials that use ctDNA and other biomarkers to detect recurrence earlier and match patients with targeted and immunotherapy treatments.
This program is supported by the Personalized Medicine Foundation, Omni Oncology and Natera.
